Copyright
©The Author(s) 2023.
World J Diabetes. Sep 15, 2023; 14(9): 1349-1368
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1349
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1349
Figure 6 Pathway enrichment analysis.
A: Prediction of diabetic retinopathy (DR)-related genes; B: Pathway enrichment analysis of DR-related genes; C and D: Intersection of genipin target and DR-related genes; E: Pathway enrichment analysis of genes which are mixed by DR-related and genipin targets. EPO: Erythropoietin; BP: Biological process-pathways and larger processes made up of the activities of multiple gene products; MF: Molecular Function-molecular activities of gene products; KEGG: Kyoto Encyclopedia of Genes and Genomes.
- Citation: Sun KX, Chen YY, Li Z, Zheng SJ, Wan WJ, Ji Y, Hu K. Genipin relieves diabetic retinopathy by down-regulation of advanced glycation end products via the mitochondrial metabolism related signaling pathway. World J Diabetes 2023; 14(9): 1349-1368
- URL: https://www.wjgnet.com/1948-9358/full/v14/i9/1349.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i9.1349